Skip to main content
. 2022 Apr 15;14(2):90–113.

Figure 1.

Figure 1

I-ATXP inhibits proliferation of HepG2, SMMC7721, and HKCI-C3 human hepatocellular carcinoma cell lines and MIHA immortalized hepatocyte cell line. Cells were incubated with I-ATXP, 5-Fluorouracil (5-Fu) as a positive control at varying dosage for 72 hours, and proliferation was measured by CCK-8 assay. The results of three independent experiments are shown. (A) HepG2, SMMC7721, HKCI-C3, and MIHA cells were treated with various doses I-ATXP (0, 0.125, 0.25, 0.5, and 1 mg/ml) for 72 h followed by CCK8 assay, and (B) HepG2, SMMC7721, HKCI-C3, and MIHA cells were treated with various doses of 5-FU (0, 0.05, 0.1, and 0.2 mg/ml) for 72 hours followed by CCK8 assay.